Landry Robert E

CIK 00015851603 companiesMIDDLETOWN, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001585160

Recent Transactions

50 trades

Award
Zymeworks Inc.$ZYME
Stock Option (Right to Buy)
2026-01-12+11,500→ 11,500 total
Award
Zymeworks Inc.$ZYME
Restricted Stock Unit
2026-01-12+7,700→ 7,700 total
Award
Zymeworks Inc.$ZYME
Stock Option (Right to Buy)
2025-08-11+62,000→ 62,000 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2025-05-14+7,333→ 7,333 total
Award
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2025-05-14+10,880→ 10,880 total
Award
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2025-02-10+25,538→ 25,538 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-02$956.65/sh−281→ 23,693 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-02$378.98/sh+400→ 23,974 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-02-02−400→ 11,787 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-31$378.98/sh+400→ 23,856 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-31$953.42/sh−282→ 23,574 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-31−400→ 12,187 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-24$378.98/sh+500→ 23,808 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-24−500→ 12,587 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-24$951.26/sh−352→ 23,456 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-23$378.98/sh+1,100→ 24,084 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-23−1,100→ 13,087 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-23$948.50/sh−776→ 23,308 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-17$932.34/sh−354→ 22,984 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-17−500→ 14,187 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-17$378.98/sh+500→ 23,338 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-12−800→ 14,687 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-12$378.98/sh+800→ 23,406 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-12$928.18/sh−568→ 22,838 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-04$378.98/sh+500→ 22,948 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-04$917.05/sh−342→ 22,606 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-04−500→ 15,487 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-03−1,100→ 15,987 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-03$378.98/sh+1,100→ 23,136 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-03$912.30/sh−688→ 22,448 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-02$888.34/sh−421→ 22,036 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-02$378.98/sh+650→ 22,457 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-02−650→ 17,087 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-28$378.98/sh+850→ 22,419 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-12-28−850→ 17,737 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-28$884.88/sh−612→ 21,807 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-12-27−750→ 18,587 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-27$872.21/sh−542→ 21,569 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-27$378.98/sh+750→ 22,111 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-12-13−1,000→ 19,337 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-13$871.12/sh−723→ 21,361 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-13$378.98/sh+1,000→ 22,084 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-12$856.71/sh−6,381→ 21,084 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-11$844.09/sh−2,552→ 27,465 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-11$844.09/sh−669→ 30,017 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-08$843.79/sh−1,013→ 30,686 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-08-23$844.00/sh−223→ 31,699 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-03-28$826.36/sh−31→ 31,922 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-03-28$820.85/sh−115→ 32,804 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-03-28$818.81/sh−10→ 32,919 total

Companies

Recent Filings

Address

C/O ZYMEWORKS INC. 108 PATRIOT DRIVE, SUITE A

MIDDLETOWN, DE, 19709

View on SEC.gov